CLINICAL_TRIALS
trial_result
· 2017-11-20
Clinical Trial Update: Pilot Trial Of Omeprazole in Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
Summary
A Phase 2 pilot trial evaluating omeprazole for idiopathic pulmonary fibrosis has completed. The study was sponsored by Newcastle-upon-Tyne Hospitals NHS Trust.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Newcastle-upon-Tyne Hospitals NHS Trust | Conditions: Idiopathic Pulmonary Fibrosis | Phase 2 | Status: COMPLETED